CTLA-4 modulator
This page covers all CTLA-4 modulator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD80/CD86.
Targets
Marketed (1)
- ABT · Shanghai Public Health Clinical Center · Immunology
Abatacept works by inhibiting T-cell activation through the CD80/CD86-CD28 costimulatory pathway.
Patent intelligence
- ctla 4 modulator patent landscape — aggregated cliff calendar, attackable patents, originator estates